FBN2 and hypercalcemia disease: As shown in Figure S1, the cCa levels decreased from 12.3 (11.4-13.1) to 10.3 (9.8-11.5) mg/dL in the lower PTHrP group (PTHrP level of ≥1.1 pmol/L but <6.3 pmol/L) and from 13.5 (12.3-14.9) to 11.1 (9.8-12) mg/dL in the higher PTHrP group (PTHrP level of ≥6.3 pmol/L) after 14 days of treatment for hypercalcemia.